United States, ex rel. Jesse Polansky, M.D., M.P.H., Petitioner v. Executive Health Resources, Inc., et al.
Case Number:
21-1052
Court:
Nature of Suit:
Firms
- Covington & Burling
- Gibson Dunn
- Haynes & Boone
- King & Spalding
- Ropes & Gray
- Sidley Austin
- Sparacino PLLC
Companies
- AdvaMed
- Executive Health Resources Inc.
- Pharmaceutical Research & Manufacturers of America
- Taxpayers Against Fraud Education Fund
- Washington Legal Foundation
Sectors & Industries:
-
July 21, 2023
The Litigation Jolting Health & Life Sciences In 2023's 2nd Half
A head-spinning spree of rulings and new lawsuits in 2023's first half is reverberating across the health care industry and auguring a dizzying denouement in the year's final months that may well upend assumptions about drug prices and approvals, the False Claims Act and the powers of federal regulators.
-
July 14, 2023
Top Government Contracts Cases Of 2023: Midyear Review
This year has already been an impactful one for government contracting lawyers, with the highest-profile False Claims Act decision in years, another decision that has raised questions about the constitutionality of whistleblower FCA cases, and COVID-19-related rulings on the president's procurement authority. Here, Law360 looks at the top court rulings on government contracts so far in 2023.
-
June 16, 2023
High Court Backs Broad FCA Dismissal Authority For Gov't
The U.S. Supreme Court on Friday ruled that the federal government has the authority to dismiss whistleblower False Claims Act cases it initially declines to intervene in, but said it must reasonably explain why it is seeking to dismiss the suit.
-
January 05, 2023
The Hottest FCA Cases & Trends To Watch In 2023
The never-not-busy False Claims Act realm will be extra active in 2023 as the U.S. Supreme Court delivers at least one FCA opinion — and perhaps two or even three — in headliner cases during a year in which attorneys are also eyeing a new circuit split and emerging enforcement frontiers.
-
January 02, 2023
Health Care & Life Sciences Litigation To Watch In 2023
Before the New Year's Eve confetti has even been swept up, lawyers specializing in health care and life sciences already have enough litigation to keep them busy for much of 2023, which is kicking off with federal courts eyeing suits that carry sweeping significance for administrative law, the False Claims Act, drug approvals, the opioid crisis and abortion rights.
-
January 02, 2023
Gov't Contracts Cases To Watch In 2023
The New Year will see the U.S. Supreme Court deciding limits on the government's ability to dismiss whistleblower False Claims Act cases, while circuit courts are expected to address the limits of procurement law. Here, Law360 looks at eight cases to watch in 2023 that have the potential to significantly impact government contractors.
-
December 06, 2022
Justices Skeptical About Limits On Gov't FCA Dismissal Right
Several U.S. Supreme Court justices seemed skeptical Tuesday of a relator's argument that the government should be barred from dismissing whistleblower False Claims Act cases it initially declines to intervene in, raising both constitutional and textual concerns.
-
November 17, 2022
Whistleblower Tells Justices FCA Dismissal Authority Limited
A whistleblower who accused a UnitedHealth unit of helping hospitals overcharge the government urged the U.S. Supreme Court on Thursday to reject the company's argument that the False Claims Act clearly allowed the government to dismiss his suit after initially declining to intervene.
-
October 25, 2022
Industry Backs Broad FCA Dismissal Authority At High Court
Legal, medical and business organizations are urging the U.S. Supreme Court not to revive a False Claims Act suit accusing a UnitedHealth unit of helping hospitals overcharge the government, saying a lower court correctly backed broad governmental authority to dismiss whistleblower cases.
-
October 18, 2022
Feds Want Justices To Back Nixing Of Whistleblower's Suit
The federal government urged the U.S. Supreme Court to back a decision to toss a whistleblower's suit accusing a company of lying to get higher Medicare repayments, saying it didn't have to intervene to dismiss the suit.